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There is increasing evidence that substances which are normally present in human or 
animal bodies may, under the certain circumstances, exhibit deleterious effects on 
genetic material, therefore acting as endogenous mutagenic agents. Since hormones 
represent one of the best studied endogenous mutagens, some research focused on the 
possible role of thyroid hormone in mutagenesis and carcinogenesis. Indeed, thyroid 
hormones accelerate aerobic metabolism and production of reactive oxygen species 
(ROS) and, therefore, may exhibit mutagenic effects in various test systems on 
mammalian cells. However, possible mutagenic effects on prokaryotic DNA has not 
been investigated so far. Hence, the aim of this research was to compare the sensitivity 
of TA 100 Salmonella typhimurium with and without metabolic activation with S9 
fraction, and human lymphocytes to possible genotoxic effects of triiodothyronine (T3). 
Therefore, we used the reverse mutation assay on S. typhimurium (Ames test) and in 
vitro Comet assay in isolated peripheral blood human lymphocytes. In both tests-
systems a broad spectrum of T3 concentrations was applied. The obtained results 
showed absence of genotoxic effects of T3 in bacterial reverse mutation assay and very 
profound genotoxic effects in human lymphocytes at concentrations higher than 15 µM. 
We only observed cytotoxic effects in bacterial system at very high T3 concentrations 
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(300 and 500 µM). In conclusion, T3 was unable to increase the level of reverse 
mutations in Ames test both with and without S9 mix. Therefore, it seems that ROS 
production in mitochondria may be the primary cause of DNA damage caused by T3 in 
mammalian cells. 
Keywords: Comet assay, DNA damage, human lymphocytes, triiodothyronine, 
TA100 Salmonella typhimurium 
 
INTRODUCTION 
Hormones, as endogenous substances, are a priori considered as non-carcinogenic and 
non-mutagenic, although there is an increased experimental and epidemiological evidence for 
their role in carcinogenesis (ĐELIĆ, 2002; KABBARAH et al., 2006; SCHIEL et al., 2006). 
Hormones may be involved in the processes of malignant transformation both at the level of 
initiation and promotion of carcinogenesis (OTHMAN et al., 2014; CAVALIERI et al., 2016). The 
high level of T3 hormone is positively associated with the risk of thymus neoplasia (BOYD et al., 
2016), prostate cancer, benign prostatic hyperplasia (LEHRER et al., 2002) and breast cancer 
(TOSOVIC et al., 2012). According to HERCBERGS (1996), thyroid hormones (TH) - 
triiodothyronine (T3) and its prohormone thyroxine (T4) are promoters of carcinogenesis through 
their important role in cell differentiation, growth, and metabolism. Later reports explained such 
effects of thyroid hormones by their involvement in promoting tumor induced angiogenesis 
(PINTO et al., 2011) and increasing  cancer cell proliferation (TSUI et al., 2008). 
On the other hand, internally produced substances can cause instability of human cancer 
by increased oxidative DNA damage that can not be remedied by DNA repair mechanisms 
(JACKSON and LOEB, 2001). In in vivo conditions, MAGSINO et al. (2000) has shown an increment 
of reactive oxygen species (ROS) production in mononuclear cells and polymorphonuclear 
leukocytes by provoking a hyperthyroid state in euthyroid healthy volunteers by giving them 
orally 60 μg/d of T3 for 7 days. Indeed, imbalanced prooxidant-antioxidant status and increased 
oxidative DNA damage are observed in patients with Graves hyperthyroidism (RYBUS-
KALINOWSKA et al. 2008; TSAI et al., 2009). Ability of TH to cause oxidative DNA lesion was 
evaluated in in vitro Comet assay in human lymphocytes (DJELIC and ANDERSON, 2003, 
ŽUKOVEC-TOPALOVIĆ et al., 2015) and sperm (DOBRZYŃSKA et al., 2004), as well as in rodent 
lymphocytes in vivo (DESIBIO et al., 2013). Increased generation of reactive oxygen species 
(ROS) in hyperthyreoid state can be explained by T3 and T4 possibility to undergo redox cycling 
due to the phenolic group presence in their structure (DJELIĆ et al., 2007) and by increased 
mitochondrial oxygen consumption (MESSARAH et al., 2010), mainly by T3 (CHENG et al., 2010).  
To our best knowledge, the mutagenicity of TH was not studied in bacterial short-term 
test systems before, although these tests can provide considerable information about cellular 
mechanisms of mutagenesis (VUKOVIĆ-GAČIĆ et al., 2006).Mutagenic properties of natural and 
synthetic hormones were studied using S. typhymurim’s reverse mutation test (Ames test) and 
almost all obtained results were negative, both with and without metabolic activation (SIDDIQUE 
et al., 2005). However, there are some experimental data showing mutagenic effects of the 
hormones in the Ames test (YAMAGUCHI, 1981; LUTZ et al., 1988). Interestingly, in YAMAGUCHI 
(1981) study, a mutagenicity of adrenaline was only observed in S. typhimurium TA 100 not 
other used strains, respectively, TA 1535, TA 1536, TA 1537, TA 1538. Similary, LUTZ et al. 
(1988) has used different strains of S. typhimurium, TA 98, TA100 and TA102 in his study of 
trenbolone, synthetic androgen hormone, mutagenicity. As explained by LUTZ et al. (1988), 
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trenbolone can penetrate bacterial cells and react with DNA only in the TA100 strain leading to a 
slight but not significant increase the number of revertants.  
Therefore, we choose to examine a mutagenic potency of T3 hormone in a concentration 
which is 103 to 105 fold higher than the physiological level of T3, with or without metabolic 
activation with a Salmonella/ microsome TA100 strain reverse mutation assay. In addition, we 
evaluated genotoxicity of T3, in concentrations: 0.005, 0.025, 0.15, 1.5, 5.0, 15, 50, 100, 200 and 
500 μM, in the in vitro Comet assay in human lymphocytes. 
 
 
MATERIALS AND METHODS 
Chemicals   
The 3,3’,5-trijodo-L-thyronine sodium salt (T3 hormone) (CAS No, 194585, Galenika 
Belgrade, Serbia) was freshly dissolved in PBS (Torlak, Belgrade, Serbia).  The stock solution of 
T3 hormone (500 μM) was diluted for an Ames test to obtain: 5, 15, 50, 100, 200 and 300 μM 
and for a Comet assay to obtain: 1.5, 5.0, 15, 50, 100 and 200 μM. 
 
Bacterial and eukaryotic cells 
S. typhimurium’s strain TA100 was used for mutagenicity testing of a wide range of T3 
concentrations and strain TA98 was used for the evaluation of enzyme activity of the S9 fraction 
in co-treatment with ethidium bromide (EtBr). While TA98 were used for determining the frame 
shift, TA100 was used to determine the base pair exchange type of mutations. 
For the Comet assay, human lymphocytes were obtained and immediately used by 
venepuncture from 5 healthy male donors (25 - 35 years of age). All of them were healthy at the 
moment of blood sampling and non-smokers. Donors who reported alcohol consumption, 
medicinal usage, exposure to diagnostic X-rays and severe aerobic physical training were 
excluded. Human blood sampling was performed in accordance with the Declaration of Helsinki 
and approved by the Ethical Committee for clinical research at the Faculty of Pharmacy in 
Belgrade Serbia (846/2).  Informed donor consent was also obtained. 
 
Media, growth conditions and S9 fraction preparation 
S. typhimurium reverse mutation assay, including media preparation, was performed by 
the methods described by MARON and AMES (1983). Bacteria were grown in minimal glucose 
medium (MG) medium at 37°C for 48 hours. 
S9 fraction was isolated from the liver of Albino Wistar male rats (170-180 g) induced 
with phenobarbital (Sigma-Aldrich, Cas No. 50-06-6) and β-naphtho flavones (Sigma-Aldrich, 
Cas No. 6051-87-2). S9 mixture contained 4% (v/v) S9 fraction, 33 mMKCl, 8 mM MgCl2, 5 
mM glucose-6-phosphate (Sigma-Aldrich, CasNo. 54010-71-8)and 4 mM NADP (Sigma-
Aldrich, CAS No. 1184-16-3) in 0.1 M phosphate buffer pH 7.4 (MARON and AMES, 1983). 
Preparation of S9 mixture obtained from the livers of Albino Wister male rats was approved by 
the Ethical Committee of the Faculty of Biology in Belgrade, University of Belgrade Serbia (EK-
BF-2015/26). 
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Evaluation of mutagenicity of T3 in Ames test 
For evaluation of the mutagenic potential of T3 two experimental procedures were 
applied: A) co-incubation of T3 concentrations (5, 15, 50, 100, 200, 300 and 500 µM) with S. 
typhimurium TA100 without the S9 fraction; B) pre-incubation of T3 concentration (5, 15, 50, 
100, 200, 300 and 500 µM) and the S9 fraction for 30 min on 37ºC, followed by incubation, and 
the final addition of S. typhimurium strain TA100.  
The enzyme activity of the S9 fraction in co-treatment with EtBr in concentration 50, 75 
and 100 μg per plate, was evaluated in the S. typhimurium strain TA98. In all above mentioned 
experimental procedures the overnight culture of S. typhimurium TA100 strain or TA98 strain 
was washed by centrifugation and resuspended in the same volume of 0.01 M MgSO4. Samples 
(0.1 ml) were added to 3 ml of molten top agar containing 0.05 mM histidine and biotin and 
poured in duplicates onto MG plates with different concentrations of T3 (5, 15, 50, 100, 200,  
300 and 500µM) with or without S9 mix (0.3 ml). PBS was used as a negative control. After 
incubation at 37°C for 48h the number of His+ revertants was determined and the presence of the 
bacterial background lawn on all plates was confirmed. 
 
Isolation of lymphocytes  
Isolation of lymphocytes from whole blood was performed with a Ficoll-Paque medium. 
After centrifugation at 1900 g for15 min, the lymphocytes formed a layer directly above the 
Ficoll-Paque. The isolated lymphocytes were washed twice in RPMI 1640 medium, each wash 
was followed by a centrifugation of 10 min at 1800 g. Finally, the supernatant was removed as 
carefully as possible without disturbing the pellet. An aliquot of 1 mL of RPMI 1640 was added 
and the pellet was resuspended.  
 
The Comet assay 
An alkaline Comet assay was performed according to SINGH et al. (1988) and TICE et al. 
(2000) technique, with slight modifications. For every treatment in the Comet assay, human 
lymphocytes from 5 donors were used. In this study the genotoxic effects of 3,3 ',5-triiodo-L-
thyronine sodium salt (T3) dissolved in PBS to experimental concentrations 0.005, 0.025, 0.15, 
1.5, 5.0, 15, 50, 100, 200 and 500 μM  were investigated. We used 100 μM hydrogen peroxide as 
the positive control (Galafarm, Skopje, Macedonia), and the solvent (PBS) for T3 was the 
negative control. 
Prior to the Comet assay, the viability of lymphocyte cells was evaluated after incubation 
for 30 min with the tested compounds using the Trypan blue dye assay. 
Microscope slides were pre-coated with 1% normal melting point agarose and were dried 
at a room temperature for at least 48 h. After centrifugation (5 min at 2000 rpm), 100 μl of cell 
suspension was mixed with 100 μl of 1% low melting point agarose (LMPA). 90 µL of the 
suspension was rapidly pipetted onto the first agarose layer and spread using a coverslip, and put 
in the fridge to solidify. After removal of the coverslip, the 90 μL of 0.5% LMPA was added as 
the third layer, spread using a coverslip and allowed to solidify at 4°C for 5 min. Afterwards, the 
slides were immersed in cold lysis solution at pH 10 (2.5 M NaCl, 100 mM EDTA, 10 mM Tris 
pH 10, 1% Triton X-100, 10% DMSO) overnight at 4°C. After lysis, the slides were placed in a 
horizontal gel electrophoresis tank to allow DNA unwinding in cold (4°C) alkaline 
electrophoresis buffer (300 mM NaOH, 1 mM EDTA, pH > 13) for 30 min. Electrophoresis were 
done at 4°C under electric current of 25 V and 300 mA for 30 min. All these steps were 
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performed under dimmed light (tank was covered with a black cloth) to prevent the occurrence 
of additional DNA damage. The slides were then neutralized with 400 mM Tris-HCl (pH 7.5) 
three times for 5 min. Then, the slides were fixed with cold methanol, dried and stored. Before 
analysis, the slides were rehydrated with ice cold distilled water and stained with 50 μL of 20 
μg/mL EtBr. 
 
Scoring of comets 
Slides were examined at 400× magnification with a fluorescent microscope (Leica, UK) 
and image analysis software (Comet Assay IV Image Analysis system, PI, UK). From each 
replicate slide, 50 nuclei were scored (a total of 100 nuclei per donor) and a tail intensity- 
percentage of tail DNA (Ti) was used to evaluate the extent of DNA migration. 
 
Statistical analysis 
The results of the Ames test, are expressed as mean values of three independent 
experiments with two replicates. Statistical analysis of the Comet assay results was performed 
using Statistica 7.0 Software. Mean values of Ti for each group and each of 5 donors in 
genotoxic and antigenotoxic treatments were calculated. Afterwards, groups of 5 values were 
formed in both treatments and compared using t-test. A difference at P< 0.05 was considered as 
statistically significant. 
 
RESULTS AND DISCUSSION 
 
Mutagenic potential of T3 in the Ames test 
According to available literature the mutagenicity of thyroid hormones was not evaluated 
before in the Ames test. Prior to testing mutagenic effects of T3 in the concentration range 5-500 
μM/plate in TA 100 Salmonella typhimurium with and without metabolic activation, we 
evaluated the enzyme activity of the S9 fraction in TA98 and TA100. The number of 
spontaneous revertants with or without the S9 fraction was in the expected range for strains, 30-
50 for TA98 and 120-200 for TA100 (MARON and AMES, 1983). A significant, more than 2 fold, 
increase in the number of revertants occurred after treating the TA98 strain with the S9 fraction 
in the presence of 50, 75 and 100 μg/plate of EtBr (Table 1). On the other hand, none of the T3 
concentrations were mutagenic in TA100, in the absence and presence of S9 metabolic activation 
in both experimental procedures (Table 2). No increase in the number of revertants occurred for 
PBS (negative control). However, in our study, we observed a slight decrease of the bacterial 
lawn at concentrations ≥300 μM, which lead to the conclusion that cytotoxic effects are present. 
Our results show the absence of mutagenic effects of T3 at all concentrations, which is consistent 
with all previous negative results of hormones in the Ames test (SIDDIQUE et al., 2005). It is 
possible that the ambiguous results of trenbolone mutagenic effects in the Ames test in LUTZ et 
al. (1988) study, originated from an absence of a twofold increase of revertants in groups 
challenged with trenbolone and/or contamination of the test substance. Similarly, controversial 
results of YAMAGUCHI (1981) probably arise from the fact that in his study, 120 was referent 
number of TA 100 Salmonella typhymurium revertants, which is not consistent with wide 
accepted range 120-200 (MARON and AMES, 1983). Although we also used S. typhimurium 
TA100 in this investigation, there was an absence of mutagenic effects of T3. Therefore, we 
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conclude that T3 was unable to exhibit mutagenic effects on S. typhimuriumTA100, both with 
and without metabolic activation using S9 mix. 
 
 
Table 1. Evaluation of enzyme activityof the S9 on TA98 Salmonella typhimurium in cotreatment with EtBr 
  Number of revertants/plate (mean ± SE) 
tested 
supstances 
 TA 98 
                 without S9                   With S9               
 0a            12,50±2,50 18,50±6,50 
 50            20,00±1,00  317,00±49,00 
EtBrb 75           19,00±3,00   177,00±16,00 
 100           21,00±6,00   133,00±12,00 
The efficacy of the of S9 (Albino Wistar liver microsomal liver fractions induced by pheno-barbital  and β -naphtho 
flavones) wasassed in cootretment with bEtBr (ethidium bromide, μM/plate) in accordance to MARON and AMES 
(1983);a0- the number of spontanious revertants of TA98 Salmonella typhimurium;  
 
Table 2. Mutagenic potential of T3 in concentration range of 5-500 μM/plate in TA 100 Salmonella 
typhimurium 
  Number of revertants/plate (mean ± SE) 
    tested supstances                                                          TA 100
  without S9 with S9 pre-incubated with 
S9   
 0a 179 ± 48 259 ± 54  
 Sb 210 ± 81 266 ± 75  
T3c 5 218 ± 5 315 ± 12 293 ± 7 
 15 160 ± 42 230 ± 43 232 ± 16 
 50 155 ± 49 228 ± 66 242 ± 17 
 100 194 ± 69 272 ± 86 252 ± 5 
 200 194 ± 58 252 ± 77  278 ± 10 
 300 188 ± 71 d 270 ± 87 d 270 ± 38 d 
 500 179 ± 82 d 258 ± 62 d  229 ± 35d 
The mutagenicity of c T3- Triiodothyronine(μM/plate)was evaluated in accordance to MARON and AMES (1983)  with 
or without addition of S9 (Albino Wistar liver microsomal liver fractions induced by pheno-barbital  and β -naphtho 
flavones);  athe number of spontanious revertants of TA100 Salmonella typhimurium; bSolvent- PBS for T3; 
d Toxicity 
manifested as an alteration in the background lawn 
 
Genotoxic potential of T3 in the Comet assay 
A cytogenetic study in humans with an impaired thyroid status (FEDOROVA et al., 1992) 
showed that hyperthyroidism may cause chromosome and chromatid aberrations. In contrast, 
DJELIĆ et al. (2006, 2007) reported that L-thyroxine does not exhibit cytogenetically detectable 
genotoxic effects in lymphocytes from the whole-blood cultures. The same groups of authors 
reported that an increment in SCE rate was found at very high concentrations which were 
comparable to accidental acute poisoning with thyroxine (BERKNER et al. 1991). On the other 
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hand, the in vitro Comet assay, which is more sensitive than cytogenetic tests, gave positive 
results in genotoxicity testing of T3 hormone on sperm (DOBRZYŃSKA et al., 2004) at 
concentrations higher than 10 μM. Although the cytobiochemical and physiological effects of T3 
are generated in a lower concentration range (0.001-0.003 μM), the higher concentrations in 
previous studies were justified due to difficulties to extrapolate a longer period of exposure in a 
laboratory in vitro conditions (CEMELI and ANDERSON, 2011). Bearing in mind all the above 
mentioned, in our study, we chose to investigate the genotoxic effects of a wide-ranging T3 
(0.005- 200 μM) on isolated human lymphocytes, which are considered as common surrogate 
cells. The Trypan blue exclusion assay was used to test the viability of cells treated. Cell 
viability of lymphocytes after the treatment with T3 at 500 μM and 100 μM doses for 30 min, 
was mostly higher >90%. In our experimental conditions, it was observed that, at lower 
concentrations, such as 0.005, 0.025, and 0.15 µM, T3 did not show a significant effect on DNA 
damage in human lymphocytes (data not shown). Treatments with 1.5 µM and 5 µM of T3 
increased average Tail intensity values by 1.7 and 1.8 fold respectively, comparing with negative 
control but without statistical significance. DNA damage in lymphocytes treated with 15 µM of 
T3 and all other higher concentrations gave rise to a significant DNA damage in a dose 
dependent manner (Figure 1). Our results are consistent with previous findings of DJELIC and 
ANDERSON (2003), although treatment duration in our study was 1.5 h shorter. MAGSINO (2000) 
in the in vivo study has observed an exacerbation of ROS in a hyperthyroid state, possibly due to 
the depression of the endogenous enzymatic antioxidant defense by increased T3 concentration 
(CHATTOPADHYAY et al., 2007). The results of the present study demonstrated that T3 
concentration of 1.5 μM was high enough to induce oxidative stress at level accompanied with 
DNA damage which was not completely repaired, and consequently was expressed as increased 
DNA migration in the Comet assay. Anyway, the underlying molecular mechanisms of T3 
genotoxicity require further investigations.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Effects of T3 in concentration range of 1.5 - 200 µM on the DNA integrity of human lymphocytes; 
C- - negative control, C+- positive control (100μM hydrogen peroxide),*significance in 
comparison with negative control (P< 0.05) 
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It has to be mentioned that concentrations of T3 in our investigation that gave significant 
DNA damage were much higher than plasma levels of T3 in severe hyperthyroidism (DE LEO et 
al., 2016), or accidental thyroxine poisoning (BERKNER et al., 1991; MAJLESI et al., 2010). 
Therefore, pathophysiologically elevated T3 probably do not cause significant DNA damage 
during the short-time period, as in our investigation. However, we assume that prolonged 
exposure to elevated levels of T3 and T4 may pose some genetic risk, as discussed by DJELIĆ et 
al. (2006). In addition, we confirmed using the Ames test that T3 is not a direct mutagen in TA 
100 S.typhimurium, but it has the ability to cause DNA damage just probably by enhancing 
mitochondrial oxygen consumption accompanied by the production of reactive oxygen species- 
ROS (LANNI et al., 2016). It is well-known that thyroid hormones strongly influence 
mitochondria as an organelle important for the production of energy necessary for various 
biochemical processes underlying cell growth and differentiation (VAITKUS et al., 2015). 
Considering that antioxidant therapy has been beneficial in the therapy of hyperthyroid patients 
(GUERRA et al., 2001), our further research will focus on finding an adequate antioxidant 
antigenotoxic agent that counteracts T3 induced oxidative DNA damage. 
 
ACKNOWLEDGMENTS 
This research was supported by the Serbian Ministry of Education and Science, grant  #III46002.               
                                 Received January16th, 2017 
                                                   Accepted April 22th, 2017 
 
REFERENCES 
BERKNER, P.D., H. STARKMAN, N. PERSON (1991): Acute thyroxineoverdose; therapy with sodium ipodate: Evaluation of 
clinicaland physiologic parameters. J. Emerg. Med., 9:129-131. 
BOYD, J.D., R. JUSKEVICIUS (2012): Mediastinal neoplasms in patients with Graves disease: a possible link between 
sustained hyperthyroidism and thymicneoplasia? Thyroid Res., 5(1): 5. 
CAVALIERI, E.L. and E.G. ROGAN (2016): Depurinating estrogen-DNA adducts, generators of cancer initiation: their 
minimization leads to cancer prevention. Clin. Transl. Med., 5(1): 12. 
CEMELI, E. and D. ANDERSON (2011): Mechanistic investigation of ROS-induced DNA damage by oestrogenic 
compounds in lymphocytes and sperm using the comet assay. Int. J. Mol. Sci., 12(5): 2783-2796. 
CHENG, S.Y., J.L. LEONARD, P.J. DAVIS (2010): Molecular aspects of thyroid hormone actions. Endocr. Rev., 31(2): 139-
170. 
DE LEO, S., S.Y. LEE, L.E. BRAVERMAN (2016): Hyperthyroidism. Lancet, 388(10047): 906-918. 
 DE SIBIO, M.T. , R.A. LUVIZOTTO, R.M. OLIMPIO, C.R. CORRÊA, J. MARINO, M. DE OLIVEIRA, S.J. CONDE, A.L. FERREIRA, C.R. 
PADOVANI, C.R. NOGUEIRA (2013): A comparative genotoxicity study of a supraphysiological dose of 
triiodothyronine (T₃) in obese rats subjected to either calorie-restricted diet or hyperthyroidism. PLoS One, 
8:e56913. 
DJELIĆ, N. (2002): Mechanisms of genotoxic effects of hormones. Genetika, 34(2-3): 59-71.  
DJELIĆ, N. and D. ANDERSON(2003): The effect of the antioxidant catalase on oestrogens, triiodothyronine, and 
noradrenaline in the Comet assay. ,Teratog. Carcinog. Mutagen., 23(S2): 69-81. 
DJELIĆ, N., B. SPREMO-POTPAREVIĆ, V. BAJIĆ, D. DJELIĆ (2006): Sister chromatid exchange and micronuclei in human 
peripheral blood lymphocytes treated with thyroxine in vitro. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 
604(1): 1-7. 
 J.BOSNJAK NEUMULLER et al.: GENOTOXICITY OF TRIIODOTHYRONINE                                         395 
DJELIĆ, N., D. DJELIĆ, B. SPREMO-POTPAREVIĆ, L. ŽIVKOVIĆ, B. MARKOVIĆ, O. LOZANČE, M. BLAGOJEVIĆ (2007): Lack of 
clastogenic effects of L-thyroxine in whole-blood cultured human lymphocytes. Genet. Mol. Biol., 30(4): 1144-
1149. 
DOBRZYŃSKA, M.M., A. BAUMGARTNER, D. ANDERSON (2004): Antioxidants modulate thyroid hormone‐and 
noradrenaline‐induced DNA damage in human sperm. Mutagenesis, 19(4): 325-330. 
FEDOROVA, A.A., E.N. ANTIPENKO, O.I. TIMCHENKO (1992): Cytogenetic changes in peripheral blood lymphocytes in 
people with impaired thyroid status. Problemy endokrinologii, 39(4): 23-25. 
GUERRA, L.N.,  S. MOIGUER, M. KARNER, M.D.C.R. DE MOLINA, C.M. SREIDER, J.A. BURDMAN (2001): Antioxidants in the 
treatment of Graves disease. IUBMB life, 51(2): 105-109. 
HERCBERGS, A. (1996): The thyroid gland as an intrinsic biologic response-modifier in advanced neoplasia-a novel 
paradigm. In Vivo, 10: 245-247. 
JACKSON, A.L., L.A. LOEB (2001): The contribution of endogenous sources of DNA damage to the multiple mutations in 
cancer. Mutat. Res. Fundam. Mol. Mech. Mutagen., 477(1): 7-21. 
KABBARAH, O., M.A. MALLON, J.D. PFEIFER, P.J. GOODFELLOW (2006): Transcriptional profiling endometrial carcinomas 
microdissected from DES‐treated mice identifies changes in gene expression associated with estrogenic tumor 
promotion. Int. J. Cancer, 119(8), 1843-1849. 
LANNI, A., M. MORENO, F. GOGLIA (2016): Mitochondrial Actions of Thyroid Hormone. Compr. Physiol., 6(4): 1591. 
LEHRER, S.,E.J. DIAMOND, N.N. STONE, M.J. DROLLER, R.G. STOCK (2002): Serum triiodothyronine is increased in men with 
prostate cancer and benign prostatic hyperplasia. J. Urol., 168(6): 2431-2433. 
LUTZ, W.K., R. DEUBER, M. CAVIEZEL, P. SAGELSDORFF, U. FRIEDERICH, C. SCHLATTER(1988):Trenbolone growth 
promotant: covalent DNA binding in rat liver and in Salmonella typhimurium, and mutagenicity in the Ames test. 
Arch.Toxicol., 62(2-3): 103-109. 
MAGSINO, C. H., W. HAMOUDA, H. GHANIM, R. BROWNE, A. ALJADA, P. DANDONA(2000): Effect of triiodothyronine on 
reactive oxygen species generation by leukocytes, indices of oxidative damage, and antioxidant reserve. 
Metabolism, 49(6): 799-803; 
MAJLESI, N., H.A. GRELLER, M.A. MCGUIGAN, T. CARACCIO, M.K. SU, G.M. CHAN (2010): Thyroid storm after pediatric 
levothyroxine ingestion. Pediatrics, 126(2): 470-473. 
MARON, D.M. and B.N. AMES (1983): Revised methods for the Salmonella mutagenicity test. Mutat. Res. Envir. Muta., 
113(3): 173-215. 
OTHMAN, E.M., H. HINTZSCHE, H. STOPPER (2014): Signaling steps in the induction of genomic damage by insulin in colon 
and kidney cells. Free Radic. Biol. Med., 68: 247-257. 
PINTO, M., P. SOARES, D. RIBATTI (2011): Thyroid hormone as a regulator of tumor induced angiogenesis. Cancer Lett., 
301: 119126.  
RYBUS-KALINOWSKA, B., K. ZWIRSKA-KORCZALA, M. KALINOWSKI, M. KUKLA, E. BIKNER, J. JOCHEM (2008): Activity of 
antioxidative enzymes and concentration of malondialdehyde as oxidative status markers in women with newly 
diagnosed Graves-Basedow disease and after thiamazole therapy leading to euthyroidism. Pol. Arch. Med. Wewn., 
118: 420-425. 
SCHIEL, R., W. BELTSCHIKOW, T. STEINER, G. STEIN (2006): Diabetes, insulin, and risk of cancer. Methods Find. Exp. Clin. 
Pharmacol., 28(3): 169-175. 
SIDDIQUE, Y.H., T. BEG, M. AFZAL (2005): Genotoxic potential of ethinylestradiol in cultured mammalian cells. Chem. 
Biol. Interact., 151(2): 133-141. 
SINGH,N.P., M.T. MCCOY, R.R. TICE, E.L. SCHNEIDER (1988): A simple technique for quantification of low levels of DNA 
damage in individual cells. Exp. Cell. Res., 175: 184-191. 
396                                                                                                             GENETIKA, Vol. 49, No2, 387-397, 2017 
TICE, R.R., E. AGURELL, D. ANDERSON, B. BURLINSON, A. HARTMANN, H. KOBAYASHI, Y. MIYAMAE, E. ROJAS, J.C. RYU, Y.F. 
SASAKI (2000): Single cell gel/Comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. 
Mol. Mutagen., 35: 206-221. 
TOSOVIC A., C. BECKER, A.G. BONDESON, L. BONDESON, U.B. ERICSSON, J. MALM, J. MANJER (2012): Prospectively 
measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int. J. Cancer, 
131(9): 2126-2133. 
TSAI, C.C., C.Y. CHENG, C.Y. LIU, S.C. KAO, H.C. KAU, W.M. HSU, Y.H. WEI (2009): Oxidative stress in patients with Graves' 
ophthalmopathy: relationship between oxidative DNA damage and clinical evolution. Eye, 23(8): 1725-1730. 
TSUI, K.H., W.C. HSIEH, M.H. LIN, P.L. CHANG, H.H. JUANG (2008): Triiodothyronine modulates cell proliferation of human 
prostatic carcinoma cells by down regulation of the B-cell translocation gene 2. Prostate, 68: 610-619. 
VAITKUS, J.A., J.S. FARRAR, F.S. CELI (2015): Thyroid hormone mediated modulation of energy expenditure. Int. J. Mol. 
Sci., 16(7): 16158-16175. 
VUKOVIĆ-GAČIĆ, B., D. SIMIĆ, J. KNEŽEVIĆ-VUKČEVIĆ (2006): Escherichia coli assay system for detection of plant 
antimutagens and their mechanisms of action. Topical issues in applied microbiology and biotechnology. Research 
SignPost, Kerala, India, 61-86. 
ŽUKOVEC TOPALOVIĆ, D., L. ŽIVKOVIĆ, A. ČABARKAPA, N. DJELIĆ, V. BAJIĆ, D. DEKANSKI, B. SPREMO-POTPAREVIĆ (2015): 
Dry olive leaf extract counteracts L-thyroxine-induced genotoxicity in human peripheral blood leukocytes in vitro. 
Oxid. med. cell longev., Article ID 762192 8. 
YAMAGUCHI, T. (1981) Mutagenicity of low molecular substances in various superoxide generating systems. Agric. Biol. 
Chem., 45: 327-330. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 J.BOSNJAK NEUMULLER et al.: GENOTOXICITY OF TRIIODOTHYRONINE                                         397 
 
GENOTOKSIČNOST TRIJODTIRONINA: EFEKTI U SOJU TA 100 Salmonella 
typhimuriumi U LJUDSKIM LIMFOCITIMA in vitro 
  
Jasna BOŠNJAK-NEUMÜLLER1, Ninoslav DJELIĆ1, Milena RADAKOVIĆ1,  
Stoimir KOLAREVIĆ2, Dragana MITIĆ-ĆULAFIĆ2, Zora DAJIĆ-STEVANOVIĆ3,  
Branka VUKOVIĆ-GAČIĆ2 and Jelena KNEŽEVIĆ-VUKČEVIĆ2, Zoran STANIMIROVIĆ2 
 
1 Katedra za biologiju, Fakultet veterinarske medicine, Univerzitet u Beogradu, Beograd, Srbija 
2Katedra za mikrobiologiju, Biološki fakultet, Univerzitet u Beogradu, Beograd, Srbija 
3Katedra za agrobotaniku, Poljoprivredni fakultet, Univerzitet u Beogradu, Beograd, Srbija 
 
 
Izvod 
Sve je više dokaza da supstance, koje su normalno prisutne u životinjskom i ljudskom 
organizmu, mogu, pod izvesnim okolnostima, da ispolje štetne efekte na nasledni materijal, 
delujući na taj način kao endogeni mutageni agensi. S obzirom da su hormoni jedna od najbolje 
proučenih grupa endogenih mutagena, pojedina istraživanja bila su usmerena ka ispitivanjima 
dejstva tireoidnih hormona u procesima mutageneze i kancerogeneze. Zaista, tireoidni hormoni 
ubrzavaju aerobni metabolizam i stvaranje reaktivnih kiseoničnih vrsta (ROS), tako da dovode 
do mutagenih efekata u različitim test sistemima na ćelijama sisara. Međutim, mogući mutageni 
efekti na prokariotsku DNK do sada nisu ispitivani. Otuda, cilj ovog istraživanja bio je da 
uporedimo osetljivost TA 100 Salmonella typhimurium u prisustvu ili odsustvu metaboličke 
aktivacije pomoću S9 frakcije i limfocita čoveka na moguće genotoksične efekte trijodtironina 
(T3).Tako smo koristili test povratnih mutacija na S. typhimurium (Ames-ov test) i in vitro komet 
test na izolovanim limfocitima periferne krvi čoveka. Širok spektar koncentracija T3 primenjen je 
u oba testa. Dobijeni rezultati pokazuju odstustvo genotoksičnih efekata T3 u testu povratnih 
mutacija na bakterijama i veoma izražene genotoksične efekte na limfocitima čoveka pri 
koncentracijama većim od 15 µM. U bakterijskom sistemu smo zapazili samo citotoksične efekte 
pri veoma visokim koncentracijama T3 (300 i 500 µM). Može se zaključiti da T3 nije bio u 
stanju da poveća nivo povratnih mutacija u Amesovom testu kako sa tako i bez metaboličke 
aktivacije sa S9 mešavinom. Prema tome, izgleda da je stvaranje ROS u mitohondrijama glavni 
uzrok oštećenja DNK u ćelijama sisara pod dejstvom T3. 
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